cme
Minimally invasive glaucoma surger
Dtsch Arztebl Int 2025; 122: 23-30. DOI: 10.3238/arztebl.m2024.0240
; ;
For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.
*Die Autorin und der Autor teilen sich die Erstautorenschaft.
Klinik für Augenheilkunde, Universitätsklinikum Tübingen: PD Dr. med. Bogomil Voykov
Klinik für Augenheilkunde, Universitätsklinikum Köln: Prof. Dr. med. Verena Prokosch
Klinik für Augenheilkunde, Universitätsklinikum Freiburg, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg: Prof. Dr. med. Jan Lübke
Klinik für Augenheilkunde, Universitätsklinikum Tübingen: PD Dr. med. Bogomil Voykov
Klinik für Augenheilkunde, Universitätsklinikum Köln: Prof. Dr. med. Verena Prokosch
Klinik für Augenheilkunde, Universitätsklinikum Freiburg, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg: Prof. Dr. med. Jan Lübke
| 1. | Crabb DP, Smith ND, Glen FC, Burton R, Garway-Heath DF: How does glaucoma look?: patient perception of visual field loss. Ophthalmology 2013; 120: 1120–6 CrossRef MEDLINE |
| 2. | EGS: European Glaucoma Society Guidelines–5th Edition. 2021. |
| 3. | Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY: Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014; 121: 2081–90 CrossRef MEDLINE |
| 4. | Höhn R, Nickels S, Schuster AK, et al.: Prevalence of glaucoma in Germany: results from the Gutenberg Health Study. Graefes Arch Clin Exp Ophthalmol 2018; 256: 1695–702 CrossRef MEDLINE |
| 5. | GBD 2019 Blindness and Vision Impairment Collaborators, Vision Loss Expert Group of the Global Burden of Disease Study: Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health 2021; 9: e144–60. |
| 6. | Finger RP, Fimmers R, Holz FG, Scholl HPN: Prevalence and causes of registered blindness in the largest federal state of Germany. Br J Ophthalmol 2011; 95: 1061–7 CrossRef MEDLINE |
| 7. | Schuster AK, Wolfram C, Pfeiffer N, Finger RP: [Ophthalmology 2019—where do we stand?: An analysis of the treatment situation in Germany]. Ophthalmologe 2019; 116: 829–37 CrossRef MEDLINE |
| 8. | Krieglstein GK: Die „großen Therapiestudien” zum Glaukom. Der Ophthalmologe 2003; 100: 484–92 CrossRef MEDLINE |
| 9. | Pillunat KR, Pillunat LE: Vaskuläre Therapiekonzepte bei Glaukompatienten. Ophthalmologe 2021; 118: 431–8 CrossRef MEDLINE |
| 10. | Abegao Pinto L, Sunaric Mégevand G, Stalmans I, et al.: European Glaucoma Society—a guide on surgical innovation for glaucoma. Br J Ophthalmol 2023; 107: 1–114 CrossRef MEDLINE |
| 11. | Kirwan JF, Lockwood AJ, Shah P, et al.: Trabeculectomy in the 21st century: a multicenter analysis. Ophthalmology 2013; 120: 2532–9 CrossRef MEDLINE |
| 12. | Panarelli JF, Moster MR, Garcia-Feijoo J, et al.: Ab-externo microshunt versus trabeculectomy in primary open-angle glaucoma: two-year results from a randomized, multicenter study. Ophthalmology 2024; 131: 266–76 CrossRef MEDLINE |
| 13. | Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC: Postoperative complications in the tube versus trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol 2012; 153: 804–14.e1 CrossRef MEDLINE PubMed Central |
| 14. | Chen DZ, Sng CCA: Safety and efficacy of microinvasive glaucoma surgery. J Ophthalmol 2017; 2017: 3182935 CrossRef MEDLINE PubMed Central |
| 15. | Saheb H, Ahmed IIK: Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol 2012; 23: 96–104 CrossRef MEDLINE |
| 16. | Klabe K, Rüfer F: „Minimally invasive glaucoma surgery“ – Kammerwinkelbasierte Verfahren im Vergleich. Ophthalmologie 2023; 120: 358–71 CrossRef MEDLINE |
| 17. | Fellman RL, Mattox C, Singh K, et al.: American glaucoma society position paper: microinvasive glaucoma surgery. Ophthalmol Glaucoma 2020; 3: 1–6 CrossRef MEDLINE PubMed Central |
| 18. | Ahmed IIK, Francesco TD, Rhee D, et al.: Long-term outcomes from the HORIZON randomized trial for a schlemm’s canal microstent in combination cataract and glaucoma surgery. Ophthalmology 2022; 129: 742–51 CrossRef MEDLINE |
| 19. | Ventura-Abreu N, García-Feijoo J, Pazos M, Biarnés M, Morales-Fernández L, Martínez-de-la-Casa JM: Twelve-month results of ab interno trabeculectomy with kahook dual blade: an interventional, randomized, controlled clinical study. Graefes Arch Clin Exp Ophthalmol 2021; 259: 2771–81 CrossRef MEDLINE |
| 20. | Le JT, Bicket AK, Wang L, Li T: Ab interno trabecular bypass surgery with iStent for open-angle glaucoma. Cochrane Database Syst Rev 2019; 3: CD012743 CrossRef MEDLINE |
| 21. | Kahale F, Chanbour W, El Zein L, Brenner J, You JY, Melki S: Phacoemulsification with and without iStent: a systematic review and meta-analysis of comparative studies. Ophthalmic Research 2023; 66: 1020–9 CrossRef MEDLINE |
| 22. | Ahmed IIK, Fea A, Au L, et al.: A prospective randomized trial comparing hydrus and iStent microinvasive glaucoma surgery implants for standalone treatment of open-angle glaucoma: The COMPARE study. Ophthalmology 2020; 127: 52–61 CrossRef MEDLINE |
| 23. | Kaplowitz K, Bussel II, Honkanen R, Schuman JS, Loewen NA: Review and meta-analysis of ab-interno trabeculectomy outcomes. Br J Ophthalmol 2016; 100: 594–600 CrossRef MEDLINE |
| 24. | Riesen M, Funk J, Töteberg-Harms M: Long-term treatment success and safety of combined phacoemulsification plus excimer laser trabeculostomy: an 8-year follow-up study. Graefes Arch Clin Exp Ophthalmol 2022; 260: 1611–21 CrossRef MEDLINE |
| 25. | Stegmann R, Pienaar A, Miller D: Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg 1999; 25: 316–22 CrossRef MEDLINE |
| 26. | Lewis RA, von Wolff K, Tetz M, et al.: Canaloplasty: circumferential viscodilation and tensioning of Schlemm’s canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: interim clinical study analysis. J Cataract Refract Surg 2007; 33: 1217–26 CrossRef MEDLINE |
| 27. | Gallardo MJ, Supnet RA, Ahmed IIK: Viscodilation of schlemm’s canal for the reduction of IOP via an ab-interno approach. Clin Ophthalmol 2018; 12: 2149–55 CrossRef MEDLINE PubMed Central |
| 28. | Koerber N, Ondrejka S: Four-year efficacy and safety of iTrack ab-interno canaloplasty as a standalone procedure and combined with cataract surgery in open-angle glaucoma. Klin Monbl Augenheilkd 2023; 240: 1394–404 CrossRef MEDLINE |
| 29. | Khaimi MA, Koerber N, Ondrejka S, Gallardo MJ: Consistency in standalone canaloplasty outcomes using the iTrack microcatheter. Clin Ophthalmol 2024; 18: 173–83 CrossRef MEDLINE PubMed Central |
| 30. | Dick HB, Mackert MJ, Ahmed IIK, et al.: Two-year performance and safety results of the MINIject supraciliary implant in patients with primary open-angle glaucoma: meta-analysis of the STAR-I, II, III trials. Am J Ophthalmol 2024; 260: 172–81 CrossRef MEDLINE |
| 31. | Bonnar J, Azuara-Blanco A: Systematic review of the method and quality of reporting of complications from studies evaluating innovative glaucoma surgical procedures. Eye 2023; 37: 1774–7 CrossRef MEDLINE PubMed Central |
| 32. | Rosdahl JA, Gupta D: Prospective studies of minimally invasive glaucoma surgeries: systematic review and quality assessment. Clin Ophthalmol 2020: 14: 231–43 CrossRef MEDLINE PubMed Central |
| 33. | Gillmann K, Hornbeak DM: Rates of visual field change and functional progression in glaucoma following trabecular microbypass implantation of iStent technologies: a meta-analysis. BMJ Open Ophthalmol 2024; 9: e001575 CrossRef MEDLINE PubMed Central |
| 34. | Montesano G, Ometto G, Ahmed IIK, et al.: Five-year visual field outcomes of the HORIZON trial. Am J Ophthalmol 2023; 251: 143–55 CrossRef MEDLINE |
| 35. | Yuan PHS, Dorling M, Shah M, Panarelli JF, Durr GM: Combined micro-invasive glaucoma surgery (MIGS) with phacoemulsification in open angle glaucoma: a systematic review and meta-analysis. Am J Ophthalmol 2024; S0002–9394(24)00333–7. |
| 36. | Agrawal P, Bradshaw SE: Systematic literature review of clinical and economic outcomes of micro-invasive glaucoma surgery (MIGS) in primary open-angle glaucoma. Ophthalmol Ther 2018; 7: 49–73 CrossRef MEDLINE PubMed Central |
| 37. | Luebke J, Boehringer D, Anton A, Daniel M, Reinhard T, Lang S: Trends in surgical glaucoma treatment in Germany between 2006 and 2018. Clin Epidemiol 2021; 13: 581–92 CrossRef MEDLINE PubMed Central |
| 38. | Sandhu A, Jayaram H, Hu K, Bunce C, Gazzard G: Ab interno supraciliary microstent surgery for open-angle glaucoma. Cochrane Database Syst Rev 2021; 5: CD012802 CrossRef MEDLINE PubMed Central |
| 39. | Reiss G, Clifford B, Vold S, et al.: Safety and effectiveness of cyPass supraciliary micro-stent in primary open-angle glaucoma: 5-year results from the COMPASS XT study. Am J Ophthalmol 2019; 208: 219–25 CrossRef MEDLINE |
| 40. | Sheybani A, Vera V, Grover DS, et al.: Gel stent versus trabeculectomy: the randomized, multicenter, gold-standard pathway study (GPS) of effectiveness and safety at 12 months. Am J Ophthalmol 2023; 252: 306–25 CrossRef MEDLINE |
| e1. | Chen XZ, Liang ZQ, Yang KY, et al.: The outcomes of XEN gel stent implantation: a systematic review and meta-analysis. Front Med (Lausanne) 2022; 9: 804847 CrossRef MEDLINE PubMed Central |
| e2. | Baker ND, Barnebey HS, Moster MR, et al.: Ab-externo microShunt versus trabeculectomy in primary open-angle glaucoma: one-year results from a 2-year randomized, multicenter study. Ophthalmology 2021; 128: 1710–21 CrossRef MEDLINE |
| e3. | Khan A, Khan AU: Comparing the safety and efficacy of preserflo microshunt implantation and trabeculectomy for glaucoma: a systematic review and meta-analysis. Acta Ophthalmol 2024; 102: e443–51 CrossRef |